Attached files
| file | filename |
|---|---|
| S-1/A - FORM S-1/A #4 - Aegerion Pharmaceuticals, Inc. | ds1a.htm |
| EX-3.1 - AMENDED AND RESTATED CERTIFICATE OF INCORPORATION - Aegerion Pharmaceuticals, Inc. | dex31.htm |
Exhibit 23.1
Consent of Independent Registered Public Accounting Firm
We consent to the reference to our firm under the caption “Experts” and to the use of our report dated August 9, 2010 (except for the paragraph under the caption “Common Stock Split” within Note 1, as to which the date is October 19, 2010), in Amendment No. 4 to the Registration Statement (Form S-1 No. 333-168721) and related Prospectus of Aegerion Pharmaceuticals, Inc. for registration of shares of its common stock.
/s/ Ernst & Young LLP
MetroPark, New Jersey
October 19, 2010